Pitavastatin
Livalo, Pitavastatin, ZYPITAMAG
HMG-CoA Reductase Inhibitor
NADAC/unit
$1.1616
No Shortage
Tier 1: 59.6%
8 Manufacturers
24 ANDAs
Pitavastatin lowers LDL cholesterol and triglycerides to reduce cardiovascular risk.
vs. brand Livalo: Generic saves up to 88% per unit
Market Intelligence
2025-07-09 Class III Recall: AvKARE
2025-07-09 Class III Recall: Orient Pharma Co., Ltd. Yunlin Plant
2025-07-09 Class III Recall: AvKARE
2025-07-09 Class III Recall: Orient Pharma Co., Ltd. Yunlin Plant
2025-03-19 Class III Recall: Kowa Pharmaceuticals America
Generic Manufacturers
AMNEAL PHARMACEUTICALS OF NY LLCAUROBINDO PHARMA LTDHETERO LABS LTD UNIT VKOWA CO LTDLUPIN LTDMYLAN PHARMACEUTICALS INCORIENT PHARMA CO LTDSAWAI USA INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.